GlassScriptPhysician profile
Christopher Samaniego
NPI 1720512155
$7,643.79
in general payments reported to CMS, 2019-2025
21 companies · $2,537 in 2025
The $2,537 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $840 · 2021: $1,415 · 2022: $1,325 · 2023: $1,266 · 2024: $260 · 2025: $2,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,359 · Food and Beverage: $1,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,358.66 |
| Food and Beverage | $1,704.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $3,161.85 | 2020-2022 | |
| Treace Medical Concepts, INC. | $2,569.48 | 2022-2025 | |
| Stryker Corporation | $747.93 | 2023-2025 | Citrefix, Augment Injectable, 7 X 23mm Citrelock Implant |
| Boston Scientific Corporation | $310.12 | 2021-2025 | 2cm Peripheral Cutting Balloon, Ams 700 |
| Imbed Biosciences INC. | $296.90 | 2023 | |
| Smith+Nephew, INC. | $92.69 | 2020 | |
| Zimmer Biomet Holdings, INC. | $78.29 | 2022-2025 | Tapestry |
| Medtronic, INC. | $55.69 | 2023 | Micra |
| Orthofix Medical, INC. | $43.80 | 2025 | Physio-Stim |
| Merck Sharp & Dohme LLC | $39.91 | 2021-2023 | Verquvo |
| Depuy Synthes Sales INC. | $37.24 | 2023 | Chia Percpasser |
| Kerecis Limited | $33.84 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $30.01 | 2023 | Nuzyra |
| Integra Lifesciences Corporation | $29.66 | 2021 | |
| Impulse Dynamics (USA) INC. | $23.80 | 2024 | Optimizer |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $18.96 | 2021 | |
| Organogenesis INC. | $16.56 | 2023 | Puraply |
| Insightec,INC | $15.50 | 2025 | Exablate |
| Horizon Therapeutics Plc | $14.83 | 2021 | |
| Amarin Pharma, INC. | $13.78 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Samaniego listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.